# Rubrik, Inc.: financial statements, quarterly

RBRK · NYSE · CIK 1943896 · [Technology](/sectors/technology.md) · fiscal year ends Jan 31

Pages: [Overview](/companies/rbrk.md) · [Financials](/companies/rbrk/financials.md) · [Filings](/companies/rbrk/filings.md) · [Insiders](/companies/rbrk/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rbrk/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2023-10-31) | period not labelled (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q4 FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [166](/filings/0001943896-24-000030.md) | [175 d](/filings/0001943896-26-000013.md) | [187](/filings/0001943896-25-000030.md) | [205](/filings/0001943896-25-000042.md) | [236](/filings/0001943896-25-000054.md) | [258 d](/filings/0001943896-26-000013.md) | [278](/filings/0001943896-26-000047.md) | [310](/filings/0001943896-26-000060.md) | [350](/filings/0001943896-25-000054.md) | [378 d](/filings/0001943896-26-000013.md) | [387](/filings/0001943896-26-000047.md) | [427](/filings/0001943896-26-000060.md) |
| Cost of revenue | $m | [33.7](/filings/0001943896-24-000030.md) | [40.0 d](/filings/0001943896-26-000013.md) | [96.0](/filings/0001943896-25-000030.md) | [55.2](/filings/0001943896-25-000042.md) | [56.1](/filings/0001943896-25-000054.md) | [58.5 d](/filings/0001943896-26-000013.md) | [60.5](/filings/0001943896-26-000047.md) | [63.6](/filings/0001943896-26-000060.md) | [68.1](/filings/0001943896-25-000054.md) | [69.7 d](/filings/0001943896-26-000013.md) | [75.3](/filings/0001943896-26-000047.md) | [92.1](/filings/0001943896-26-000060.md) |
| Gross profit | $m | [132](/filings/0001943896-24-000030.md) | [135 d](/filings/0001943896-26-000013.md) | [91.3](/filings/0001943896-25-000030.md) | [150](/filings/0001943896-25-000042.md) | [180](/filings/0001943896-25-000054.md) | [200 d](/filings/0001943896-26-000013.md) | [218](/filings/0001943896-26-000047.md) | [246](/filings/0001943896-26-000060.md) | [282](/filings/0001943896-25-000054.md) | [308 d](/filings/0001943896-26-000013.md) | [312](/filings/0001943896-26-000047.md) | [335](/filings/0001943896-26-000060.md) |
| Research and development | $m | [51.4](/filings/0001943896-24-000030.md) | [59.1 d](/filings/0001943896-26-000013.md) | [285](/filings/0001943896-25-000030.md) | [86.2](/filings/0001943896-25-000042.md) | [80.1](/filings/0001943896-25-000054.md) | [80.0 d](/filings/0001943896-26-000013.md) | [81.8](/filings/0001943896-26-000047.md) | [92.1](/filings/0001943896-26-000060.md) | [97.6](/filings/0001943896-25-000054.md) | [102 d](/filings/0001943896-26-000013.md) | [114](/filings/0001943896-26-000047.md) | [127](/filings/0001943896-26-000060.md) |
| Operating income | $m | [(65.3)](/filings/0001943896-24-000030.md) | [(83.1) d](/filings/0001943896-26-000013.md) | [(725)](/filings/0001943896-25-000030.md) | [(168)](/filings/0001943896-25-000042.md) | [(125)](/filings/0001943896-25-000054.md) | [(116) d](/filings/0001943896-26-000013.md) | [(93.1)](/filings/0001943896-26-000047.md) | [(94.5)](/filings/0001943896-26-000060.md) | [(75.5)](/filings/0001943896-25-000054.md) | [(82.4) d](/filings/0001943896-26-000013.md) | [(52.6)](/filings/0001943896-26-000047.md) | [(71.9)](/filings/0001943896-26-000060.md) |
| Interest expense | $m | [9.0](/filings/0001943896-24-000030.md) | [9.6 d](/filings/0001943896-25-000012.md) | [10.6](/filings/0001943896-24-000009.md) | [10.2](/filings/0001943896-24-000018.md) | [10.3](/filings/0001943896-24-000030.md) | [10.1 d](/filings/0001943896-25-000012.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [15.0](/filings/0001943896-24-000030.md) | [7.4 d](/filings/0001943896-26-000013.md) | [(1.1)](/filings/0001943896-25-000030.md) | [4.2](/filings/0001943896-25-000042.md) | [1.9](/filings/0001943896-25-000054.md) | [1.3 d](/filings/0001943896-26-000013.md) | [1.3](/filings/0001943896-26-000047.md) | [1.8](/filings/0001943896-26-000060.md) | [2.9](/filings/0001943896-25-000054.md) | [16.4 d](/filings/0001943896-26-000013.md) | [4.6](/filings/0001943896-26-000047.md) | [5.5](/filings/0001943896-26-000060.md) |
| Net income | $m | [(86.3)](/filings/0001943896-24-000030.md) | [(97.5) d](/filings/0001943896-26-000013.md) | [(732)](/filings/0001943896-25-000030.md) | [(177)](/filings/0001943896-25-000042.md) | [(131)](/filings/0001943896-25-000054.md) | [(115) d](/filings/0001943896-26-000013.md) | [(102)](/filings/0001943896-26-000047.md) | [(95.9)](/filings/0001943896-26-000060.md) | [(63.8)](/filings/0001943896-25-000054.md) | [(87.0) d](/filings/0001943896-26-000013.md) | [(41.9)](/filings/0001943896-26-000047.md) | [(61.8)](/filings/0001943896-26-000060.md) |
| Diluted EPS | $ per share | [(1.41)](/filings/0001943896-24-000030.md) | not reported | [(11.48)](/filings/0001943896-25-000030.md) | [(0.98)](/filings/0001943896-25-000042.md) | [(0.71)](/filings/0001943896-25-000054.md) | not reported | [(0.53)](/filings/0001943896-26-000047.md) | [(0.49)](/filings/0001943896-26-000060.md) | [(0.32)](/filings/0001943896-25-000054.md) | not reported | [(0.21)](/filings/0001943896-26-000047.md) | [(0.30)](/filings/0001943896-26-000060.md) |
| Basic EPS | $ per share | [(1.41)](/filings/0001943896-24-000030.md) | not reported | [(11.48)](/filings/0001943896-25-000030.md) | [(0.98)](/filings/0001943896-25-000042.md) | [(0.71)](/filings/0001943896-25-000054.md) | not reported | [(0.53)](/filings/0001943896-26-000047.md) | [(0.49)](/filings/0001943896-26-000060.md) | [(0.32)](/filings/0001943896-25-000054.md) | not reported | [(0.21)](/filings/0001943896-26-000047.md) | [(0.30)](/filings/0001943896-26-000060.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-10-31) | period not labelled (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [130](/filings/0001943896-25-000012.md) | [503](/filings/0001943896-24-000009.md) | [142](/filings/0001943896-24-000018.md) | [104](/filings/0001943896-24-000030.md) | [186](/filings/0001943896-26-000013.md) | [284](/filings/0001943896-25-000030.md) | [323](/filings/0001943896-25-000042.md) | [307](/filings/0001943896-25-000054.md) | [380](/filings/0001943896-26-000060.md) | [429](/filings/0001943896-26-000047.md) | [416](/filings/0001943896-26-000060.md) |
| Current assets | $m | not reported | [549](/filings/0001943896-25-000012.md) | [853](/filings/0001943896-24-000009.md) | [889](/filings/0001943896-24-000018.md) | [944](/filings/0001943896-24-000030.md) | [1,078](/filings/0001943896-26-000013.md) | [1,117](/filings/0001943896-25-000030.md) | [1,929](/filings/0001943896-25-000042.md) | [2,067](/filings/0001943896-25-000054.md) | [2,224](/filings/0001943896-26-000060.md) | [2,224](/filings/0001943896-26-000047.md) | [2,272](/filings/0001943896-26-000060.md) |
| Total assets | $m | not reported | [874](/filings/0001943896-25-000012.md) | [1,166](/filings/0001943896-24-000009.md) | [1,218](/filings/0001943896-24-000018.md) | [1,269](/filings/0001943896-24-000030.md) | [1,423](/filings/0001943896-26-000013.md) | [1,475](/filings/0001943896-25-000030.md) | [2,389](/filings/0001943896-25-000042.md) | [2,549](/filings/0001943896-25-000054.md) | [2,767](/filings/0001943896-26-000060.md) | [2,768](/filings/0001943896-26-000047.md) | [2,846](/filings/0001943896-26-000060.md) |
| Current liabilities | $m | not reported | [656](/filings/0001943896-25-000012.md) | [738](/filings/0001943896-24-000009.md) | [777](/filings/0001943896-24-000018.md) | [817](/filings/0001943896-24-000030.md) | [950](/filings/0001943896-26-000013.md) | [961](/filings/0001943896-25-000030.md) | [1,060](/filings/0001943896-25-000042.md) | [1,163](/filings/0001943896-25-000054.md) | [1,314](/filings/0001943896-26-000060.md) | [1,280](/filings/0001943896-26-000047.md) | [1,384](/filings/0001943896-26-000060.md) |
| Total liabilities | $m | not reported | [1,578](/filings/0001943896-25-000012.md) | [1,681](/filings/0001943896-24-000009.md) | [1,717](/filings/0001943896-24-000018.md) | [1,790](/filings/0001943896-24-000030.md) | [1,977](/filings/0001943896-26-000013.md) | [2,031](/filings/0001943896-25-000030.md) | [2,953](/filings/0001943896-25-000042.md) | [3,073](/filings/0001943896-25-000054.md) | [3,286](/filings/0001943896-26-000060.md) | [3,250](/filings/0001943896-26-000047.md) | [3,346](/filings/0001943896-26-000060.md) |
| Long-term debt | $m | not reported | [287](/filings/0001943896-25-000012.md) | [297](/filings/0001943896-24-000009.md) | [307](/filings/0001943896-24-000018.md) | [317](/filings/0001943896-24-000030.md) | [322](/filings/0001943896-25-000030.md) | [323](/filings/0001943896-25-000030.md) | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [(1,325)](/filings/0001943896-24-000030.md) | [(1,419)](/filings/0001943896-26-000013.md) | [(515)](/filings/0001943896-25-000042.md) | [(499)](/filings/0001943896-25-000054.md) | [(521)](/filings/0001943896-25-000054.md) | [(554)](/filings/0001943896-26-000060.md) | [(557)](/filings/0001943896-26-000060.md) | [(564)](/filings/0001943896-26-000060.md) | [(524)](/filings/0001943896-25-000054.md) | [(520)](/filings/0001943896-26-000060.md) | [(481)](/filings/0001943896-26-000060.md) | [(499)](/filings/0001943896-26-000060.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2023-10-31) | period not labelled (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q4 FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [6.9 d](/filings/0001943896-24-000030.md) | [12.8 d](/filings/0001943896-26-000013.md) | [(31.4)](/filings/0001943896-25-000030.md) | [(27.1) d](/filings/0001943896-25-000042.md) | [23.1 d](/filings/0001943896-25-000054.md) | [83.6 d](/filings/0001943896-26-000013.md) | [39.7](/filings/0001943896-26-000047.md) | [64.7 d](/filings/0001943896-26-000060.md) | [85.5 d](/filings/0001943896-25-000054.md) | [93.0 d](/filings/0001943896-26-000013.md) | [81.7](/filings/0001943896-26-000047.md) | [76.8 d](/filings/0001943896-26-000060.md) |
| Capital expenditure | $m | [1.5 d](/filings/0001943896-24-000030.md) | [3.0 d](/filings/0001943896-26-000013.md) | [3.6](/filings/0001943896-25-000030.md) | [2.6 d](/filings/0001943896-25-000042.md) | [5.1 d](/filings/0001943896-25-000054.md) | [5.6 d](/filings/0001943896-26-000013.md) | [2.9](/filings/0001943896-26-000047.md) | [3.5 d](/filings/0001943896-26-000060.md) | [4.7 d](/filings/0001943896-25-000054.md) | [18.5 d](/filings/0001943896-26-000013.md) | [4.3](/filings/0001943896-26-000047.md) | [5.6 d](/filings/0001943896-26-000060.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2023-04-30) | period not labelled (2023-07-31) | period not labelled (2023-10-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [59.9](/filings/0001943896-24-000009.md) | [60.3](/filings/0001943896-24-000018.md) | [61.0](/filings/0001943896-24-000030.md) | [63.8](/filings/0001943896-25-000030.md) | [180](/filings/0001943896-25-000042.md) | [184](/filings/0001943896-25-000054.md) | [192](/filings/0001943896-26-000047.md) | [195](/filings/0001943896-26-000060.md) | [198](/filings/0001943896-25-000054.md) | [204](/filings/0001943896-26-000047.md) | [206](/filings/0001943896-26-000060.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.